These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 3813729)

  • 1. High-dose intravenous immunoglobulin in the management of myasthenia gravis.
    Bonaventura I; Ponseti J; Arnau E; Matias-Guiu J; Codina Puiggros A
    Arch Intern Med; 1987 Feb; 147(2):207, 211. PubMed ID: 3813729
    [No Abstract]   [Full Text] [Related]  

  • 2. [Myasthenia gravis (1). Experimental myasthenia gravis--a tool for the study of the pathogenesis, diagnosis and treatment of myasthenia gravis].
    Heilbronn E
    Lakartidningen; 1978 Oct; 75(41):3663-4, 3669. PubMed ID: 692231
    [No Abstract]   [Full Text] [Related]  

  • 3. High-dose intravenous immunoglobulin for the treatment of MuSK antibody-positive seronegative myasthenia gravis.
    Takahashi H; Kawaguchi N; Nemoto Y; Hattori T
    J Neurol Sci; 2006 Sep; 247(2):239-41. PubMed ID: 16876198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose intravenous immunoglobulin for myasthenia gravis.
    Sakano T; Hamasaki T; Shimizu H; Harada Y; Ueda K
    Hiroshima J Med Sci; 1988 Mar; 37(1):7-9. PubMed ID: 3410736
    [No Abstract]   [Full Text] [Related]  

  • 5. MuSK-antibody positive myasthenia gravis: questions from the clinic.
    Sanders DB; Juel VC
    J Neuroimmunol; 2008 Sep; 201-202():85-9. PubMed ID: 18684517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of plasma exchange in management of myasthenia gravis (author's transl)].
    Arahata K; Sato T; Narabayashi H
    Rinsho Shinkeigaku; 1981 Jul; 21(7):597-606. PubMed ID: 7307400
    [No Abstract]   [Full Text] [Related]  

  • 7. [Ocular myasthenia: a diagnostic and management challenge--a review].
    Langmann A; Lindner S; Koch M; Diez J
    Klin Monbl Augenheilkd; 2004 Feb; 221(2):77-86. PubMed ID: 14986204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma exchange in myasthenia gravis.
    Kuks JB; Das PC
    Int J Artif Organs; 1998 Apr; 21(4):188-91. PubMed ID: 9649057
    [No Abstract]   [Full Text] [Related]  

  • 9. High-dose intravenous immunoglobulin in myasthenia gravis.
    Evoli A; Palmisani MT; Bartoccioni E; Padua L; Tonali P
    Ital J Neurol Sci; 1993 Apr; 14(3):233-7. PubMed ID: 8314677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A clinical model for regulation of the humoral immune response].
    Fateh-Moghadam A; Besinger U; Geursen RG
    Beitr Infusionther Klin Ernahr; 1982; 9():69-79. PubMed ID: 6890810
    [No Abstract]   [Full Text] [Related]  

  • 11. [Long-term treatment with 7S immunoglobulins in myasthenia gravis. Preliminary clinical results].
    Bamberg C; Janzen RW; Szabados M
    Nervenarzt; 1996 Apr; 67(4):327-32. PubMed ID: 8684513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose intravenous immunoglobulin in transient neonatal myasthenia gravis.
    Bassan H; Muhlbaur B; Tomer A; Spirer Z
    Pediatr Neurol; 1998 Feb; 18(2):181-3. PubMed ID: 9535308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous immune globulin in myasthenia gravis.
    Gajdos P
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):49-51. PubMed ID: 8033435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis. Myasthenia Gravis Clinical Study Group.
    Gajdos P; Chevret S; Clair B; Tranchant C; Chastang C
    Ann Neurol; 1997 Jun; 41(6):789-96. PubMed ID: 9189040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Indications for plasmapheresis in myasthenia gravis ].
    de Crousaz G
    Ther Umsch; 1982 Jul; 39(7):537-40. PubMed ID: 7123506
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibody-negative acquired myasthenia gravis: successful therapy with plasma exchange.
    Miller RG; Milner-Brown HS; Dau PC
    Muscle Nerve; 1981; 4(3):255. PubMed ID: 7242562
    [No Abstract]   [Full Text] [Related]  

  • 17. Lack of inter-animal cross-reaction of anti-acetylcholine receptor antibodies at the receptor-binding site as demonstrated by heterologous anti-idiotype antisera: implications for immunotherapy of myasthenia gravis.
    Barkas T; Simpson JA
    Clin Exp Immunol; 1982 Jan; 47(1):119-26. PubMed ID: 7094417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myasthenia gravis.
    Khadilkar SV; Sahni AO; Patil SG
    J Assoc Physicians India; 2004 Nov; 52():897-904. PubMed ID: 15906843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymectomy in myasthenia gravis: the timing of surgery and significance of thymic pathology.
    Rubin JW; Ellison RG; Moore HV; Pai GP
    Am Surg; 1981 Apr; 47(4):152-6. PubMed ID: 7224364
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antibodies to acetylcholine receptor. Diagnosis and therapeutic interest in myasthenia gravis (author's transl)].
    de Crousaz G
    Ann Chir; 1980 Mar; 34(3):188-92. PubMed ID: 7369693
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.